Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CSNK1E | P49674 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.38 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.38 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.38 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.38 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.38 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.38 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.38 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27788516 | 1.00 | CSNK1E (0.39) | CSNK1EKDM4ELMNAUSP2ALOX15 | |
| SCHEMBL6687170 | 1.00 | CSNK1E (0.39) | CSNK1EKDM4ELMNAUSP2ALOX15 | |
| SCHEMBL6689648 | 0.99 | CSNK1E (0.37) | CSNK1EKDM4ELMNAUSP2ALOX15 | |
| SCHEMBL207035 | 0.96 | ALDH1A1 (0.38) | CSNK1EKDM4ELMNAUSP2ALOX15 | |
| SCHEMBL28158239 | 0.95 | ALDH1A1 (0.37) | CSNK1EKDM4ELMNAUSP2ALOX15 | |
| SCHEMBL4218257 | 0.90 | ATM (0.39) | KDM4ELMNAHTTNPC1RAB9A | |
| SCHEMBL7910549 | 0.87 | ATM (0.43) | KDM4ELMNAUSP2ALOX15ALOX12 | |
| SCHEMBL9542830 | 0.86 | ATM (0.40) | KDM4ELMNAHTTRAB9ASMN1; SMN2 | |
| SCHEMBL6694887 | 0.83 | ATM (0.38) | CSNK1EKDM4ELMNAUSP2ALOX15 | |
| SCHEMBL8531770 | 0.82 | PRSS1 (0.46) | LMNANPC1SMN1; SMN2HDAC3HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101736158-B | Copper extracting agent | ZHENGZHOU DEZHONG CHEMICAL REAGENT FACTORY | 2012-12-19 | — | — | CN | claimed |
| CN-1788096-A | Method for extracting copper from leaching solution at elevated temperature | COGNIS CORP (US) | 2006-06-14 | — | — | CN | claimed |
| US-20040258590-A1 | Method for extracting copper from leach solutions at elevated temperatures | COGNIS CORPORATION (COGNIS CORP.) | 2004-12-23 | — | — | US | claimed |
| WO-2004104238-A2 | METHOD FOR EXTRACTING COPPER FROM LEACH SOLUTIONS AT ELEVATED TEMPERATURES | COGNIS CORPORATION (US) | 2004-12-02 | — | — | WO | claimed |
| WO-1993016204-A2 | PROCESS AND APPARATUS FOR EXTRACTING SOLUTES FROM THEIR AQUEOUS SOLUTIONS | COGNIS, INC. (US) | 1993-08-19 | — | — | WO | claimed |
| CN-101573163-B | More efficient ether modifiers for copper extractant formulations | COGNIS IP MAN GMBH | 2013-01-30 | — | — | CN | disclosed |
| CN-101736158-B | Copper extracting agent | ZHENGZHOU DEZHONG CHEMICAL REAGENT FACTORY | 2012-12-19 | — | — | CN | disclosed |
| US-7993613-B2 | aldoxime extractants with optional ketoxime extractants; branched chain ether equilibrium modifiers; 2-hydroxy-5-heptylbenzaldoxime; tert-butyl octyl ether; copper sulfate | COGNIS IP MANAGEMENT GMBH (DE) | 2011-08-09 | — | — | US | disclosed |
| CN-101736158-A | Copper extracting agent | ZHENGZHOU DEZHONG CHEMICAL REA | 2010-06-16 | — | — | CN | disclosed |
| CN-101573163-A | More efficient ether modifiers for copper extractant formulations | COGNIS IP MAN GMBH (DE) | 2009-11-04 | — | — | CN | disclosed |
| EP-2104542-A2 | MORE EFFICIENT ETHER MODIFIERS FOR COPPER EXTRACTANT FORMULATIONS | Cognis IP Management GmbH (DE) | 2009-09-30 | — | — | EP | disclosed |
| US-7585475-B2 | Highly-conductive copper extractant formulations | COGNIS IP MANAGEMENT GMBH (DE) | 2009-09-08 | — | — | US | disclosed |
| WO-2008088473-A2 | MORE EFFICIENT ETHER MODIFIERS FOR COPPER EXTRACTANT FORMULATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-07-24 | — | — | WO | disclosed |
| US-20080175772-A1 | MORE EFFICIENT ETHER MODIFIERS FOR COPPER EXTRACTANT FORMULATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-07-24 | — | — | US | disclosed |
| WO-2008021129-A2 | HIGHLY-CONDUCTIVE COPPER EXTRACTANT FORMULATIONS | COGNIS IP MANAGEMENT GMBH (DE) | 2008-02-21 | — | — | WO | disclosed |
| US-20080035893-A1 | Highly-conductive copper extractant formulations | COGNIS IP MANAGEMENT GMBH (DE) | 2008-02-14 | — | — | US | disclosed |
| CN-1788096-A | Method for extracting copper from leaching solution at elevated temperature | COGNIS CORP (US) | 2006-06-14 | — | — | CN | disclosed |
| US-20040258590-A1 | Method for extracting copper from leach solutions at elevated temperatures | COGNIS CORPORATION (COGNIS CORP.) | 2004-12-23 | — | — | US | disclosed |
| WO-2004104238-A2 | METHOD FOR EXTRACTING COPPER FROM LEACH SOLUTIONS AT ELEVATED TEMPERATURES | COGNIS CORPORATION (US) | 2004-12-02 | — | — | WO | disclosed |
| WO-1993016204-A2 | PROCESS AND APPARATUS FOR EXTRACTING SOLUTES FROM THEIR AQUEOUS SOLUTIONS | COGNIS, INC. (US) | 1993-08-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080035893-A1 | Highly-conductive copper extractant formulations | KMO, PNPO, SOD1 | CSNK1E 1469/4885KDM4E 342/4885LMNA 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.